@pickettbri Morning showers are just to wake yourself up a bit and help with bedhead. Evening showers are for the soul. I alternate but crawling into fresh sheets when youre clean is 🤌
@pickettbri Oh my gosh I’m so sorry, that’s really rough. If it was a pretty significant amount of money lost you could consider submitting a homeowners insurance claim. Could also contact the fridge manufacturer to complain if it’s not super old.
Killer T cells are beautiful! This high resolution/rapid acquisition video of a T cell attacking a lymphoma cancer cell was captured on a specialized Lattice Light Sheet microscope with the help of my wonderful collaborators @HHMIJanelia. See more details in the thread below.
Super happy we got the chance to collaborate with scientists @HHMIJanelia to capture ultra-high resolution 3D electron microscopy data of a T cell killing a cancer cell. Here's a peak at the data. Our recent Science cover image is a reconstruction of this real imaging data.
I’m concerned about the new #BA2 sub variant of #Omicron. In the left panel, you see it is surging (light green) to almost half of all Danish 🇩🇰 #Omicron cases—surpassing the old Omicron BA1 variant by a lot. Either it’s much faster transmission or it evades immunity even more.👇
Retrospective assessment demonstrates potential predictive role of ColXa1 expression in ER+/HER2+ #breastcancer response to adjuvant therapy #biomarkers#IHC https://t.co/p8OvDpmRxv
A highly interesting and (seemingly) well-controlled study demonstrating the potential of the Herpes Virus Entry Mediator (HVEM) protein as a potential prognostic marker and immune checkpoint target for malignant melanoma that corr…https://t.co/6pV85myZCB https://t.co/jlisBekoyc
The Moon will officially reach its full phase early Saturday morning EDT, and it will look full beginning this evening and on Friday the 13th. 🌕 But there’s no reason to be nervous about the “Harvest Moon.” Learn more at: https://t.co/0B2cyexlM4
Parker Institute unveils positive phase 1 results for treatment of metastatic pancreatic cancer with four drug combo including gemcitabine/nab-paclitaxel/anti-CD40/anti-PD-1 therapy
#immunotherapy#pancreaticcancer https://t.co/2t51E6Txdv
IP6 has been linked to activating MLKL, an executioner protein responsible for cell necroptosis-- posing major implications for the treatment of inflammatory conditions. Future efforts are gearing towards drug development to block IP6 from binding with MLKL #inflammation
RT @MDBiosciences: cant wait to see some in vivo data on this antibody! My cat allergies are thus far woefully untreated by most anti-allergy medication #allergy#immunology#pharma https://t.co/Kdjo2dUYcY